Tandem Diabetes Care, Inc.

TNDM

$14.52

Name : Tandem Diabetes Care, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $981,108,736.00

EPSttm : -3.08

Tandem Diabetes Care, Inc.

$14.52

3.26%

$0.49

Float Short %

11.86

Margin Of Safety %

Put/Call OI Ratio

0.81

EPS Next Q Diff

0.39

EPS Last/This Y

-0.69

EPS This/Next Y

1.22

Price

14.51

Target Price

20.48

Analyst Recom

2.38

Performance Q

-8.39

Relative Volume

0.89

Beta

1.49

Ticker: TNDM

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	TNDM	12.5	0.74	0.81	11719
2025-09-09	TNDM	12.55	0.75	0.20	11758
2025-09-10	TNDM	12.36	0.74	0.31	11811
2025-09-11	TNDM	12.78	0.74	3.61	11810
2025-09-12	TNDM	12.27	0.88	3.11	12906
2025-09-15	TNDM	12.09	0.89	0.26	12938
2025-09-16	TNDM	12.43	0.90	0.47	12987
2025-09-17	TNDM	12.18	0.89734228971963	0.14159292035398	12993
2025-09-18	TNDM	13.24	0.89	0.37	13063
2025-09-22	TNDM	13.05	1.04	0.04	10916
2025-09-23	TNDM	12.77	0.99	0.37	11221
2025-09-24	TNDM	12.65	0.98	0.20	11293
2025-09-25	TNDM	11.97	0.98	0.36	11342
2025-09-26	TNDM	11.98	0.98	0.15	11418
2025-09-29	TNDM	11.79	0.97	1.15	11526
2025-09-30	TNDM	12.15	0.97	0.19	11607
2025-10-01	TNDM	12.4	0.95	0.08	11778
2025-10-02	TNDM	13.11	0.94	0.06	11842
2025-10-03	TNDM	14.71	0.90	0.05	12167
2025-10-06	TNDM	15	0.84	0.18	12593
2025-10-07	TNDM	14.53	0.81	0.78	12789
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	TNDM	12.50	7.7	118.2	-2.21
2025-09-09	TNDM	12.57	7.7	117.4	-2.21
2025-09-10	TNDM	12.38	7.7	118.8	-2.25
2025-09-11	TNDM	12.79	7.7	115.5	-2.25
2025-09-12	TNDM	12.28	7.7	120.5	-2.25
2025-09-15	TNDM	12.10	7.0	118.7	-2.25
2025-09-16	TNDM	12.43	7.0	115.9	-2.18
2025-09-17	TNDM	12.19	7.0	119.2	-2.18
2025-09-18	TNDM	13.23	7.0	112.0	-2.18
2025-09-19	TNDM	12.57	7.0	121.3	-2.18
2025-09-22	TNDM	13.06	7.3	115.1	-2.18
2025-09-23	TNDM	12.77	7.3	119.3	-2.18
2025-09-24	TNDM	12.65	7.3	118.5	-2.18
2025-09-25	TNDM	11.96	7.3	121.4	-2.18
2025-09-26	TNDM	12.00	7.3	117.5	-2.18
2025-09-29	TNDM	11.79	7.3	119.0	-2.18
2025-09-30	TNDM	12.16	7.3	115.7	-2.17
2025-10-01	TNDM	12.41	7.3	116.4	-2.17
2025-10-02	TNDM	13.10	7.3	114.0	-2.17
2025-10-03	TNDM	14.72	7.3	109.4	-2.16
2025-10-06	TNDM	15.02	7.3	107.8	-2.16
2025-10-07	TNDM	14.51	7.3	120.1	-2.16
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	TNDM	5.34	14.42	8.62
2025-09-09	TNDM	5.34	14.42	8.62
2025-09-10	TNDM	5.34	14.42	8.62
2025-09-11	TNDM	5.34	14.42	9.95
2025-09-12	TNDM	3.64	14.42	9.95
2025-09-15	TNDM	3.56	14.43	9.95
2025-09-16	TNDM	3.56	14.43	9.95
2025-09-17	TNDM	3.56	14.43	9.95
2025-09-18	TNDM	3.56	14.43	9.95
2025-09-19	TNDM	3.56	14.43	9.95
2025-09-22	TNDM	3.56	14.46	9.95
2025-09-23	TNDM	3.56	14.46	9.95
2025-09-24	TNDM	3.56	14.46	9.95
2025-09-25	TNDM	3.56	14.46	11.86
2025-09-26	TNDM	3.56	14.46	11.86
2025-09-29	TNDM	3.56	14.46	11.86
2025-09-30	TNDM	3.56	14.46	11.86
2025-10-01	TNDM	3.56	14.46	11.86
2025-10-02	TNDM	3.56	14.46	11.86
2025-10-03	TNDM	3.56	14.46	11.86
2025-10-06	TNDM	3.56	12.43	11.86
2025-10-07	TNDM	3.56	12.43	11.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.48

Avg. EPS Est. Current Quarter

-0.33

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

3.56

Institutional Transactions

12.43

Beta

1.49

Average Sales Estimate Current Quarter

235

Average Sales Estimate Next Quarter

286

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.7

Max Drawdown 5-Year %

-93.4

Target Price

20.48

P/E

Forward P/E

PEG

P/S

0.98

P/B

7.36

P/Free Cash Flow

EPS

-3.09

Average EPS Est. Cur. Y

-2.16

EPS Next Y. (Est.)

-0.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-20.51

Relative Volume

0.89

Return on Equity vs Sector %

-179.3

Return on Equity vs Industry %

-172.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

120.1

Tandem Diabetes Care, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 2650

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

stock quote shares TNDM – Tandem Diabetes Care, Inc. Stock Price stock today

news today TNDM – Tandem Diabetes Care, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch TNDM – Tandem Diabetes Care, Inc. yahoo finance google finance

stock history TNDM – Tandem Diabetes Care, Inc. invest stock market

stock prices TNDM premarket after hours

ticker TNDM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TNDM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y